In addition, the spatial pattern of tau PET often matches brain regions that are clinically affected and show evidence of neurodegeneration on FDG-PET or MRI [25–28] increasing the confidence that the underlying syndrome is due to AD. Here, MAPT is linked to Alzheimer disease.